Related Experiment Video

Updated: Mar 20, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K

Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic Sustainability

Rodolfo Montironi1, Matteo Santoni2, Francesca Tartari3

  • 11   Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy.

Archives of Pathology & Laboratory Medicine
|May 28, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.6K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K
Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.6K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.2K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

Articles linked to this work by shared authors, journal, and citation graph.

Molecular pathology of urothelial carcinoma.

Human pathology·2021

Adjuvant therapy in renal cell carcinoma: is it the right strategy to inhibit VEGF?

Translational andrology and urology·2021

Narrative review: predicting future molecular and clinical profiles of prostate cancer in the United States.

Translational andrology and urology·2021

TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative review.

Translational andrology and urology·2021

Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

Translational andrology and urology·2021

Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?

Translational andrology and urology·2021

Streamlining Urinary Tract Infection Evaluation in a Large Pediatric Hospital System: Feasibility of Reflex Urine Culture After Urinalysis With Microscopy.

Archives of pathology & laboratory medicine·2026

Experience of the United States-Canadian Mesothelioma Reference Panel 1985-2026: Historical Review and New Developments in Mesothelial Pathology.

Archives of pathology & laboratory medicine·2026

From Residency to Practice: Overcoming Employment Obstacles for Non-US Citizen Pathologists in the United States.

Archives of pathology & laboratory medicine·2026

Cellular Viability of Whole Blood Specimens Is a Sensitive Indicator of Transport Conditions.

Archives of pathology & laboratory medicine·2026

Critical Limits and Clinical Recommendations for Notification of Life-Threatening Glucose Test Results in the 21st Century.

Archives of pathology & laboratory medicine·2026

Contemporary Updates on Subtypes of Prostate Cancer.

Archives of pathology & laboratory medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us